CAS 108061-03-6

Ketorolac Ethyl Ester (Ethyl 5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylate)

CAS: 108061-03-6

Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoi

Formula: C₁₇H₁₇NO₃

Color and Shape: Off-White Solid

Molecular weight: 283.12084

Ref: 45-1A14050

Ketorolac EP Impurity J

CAS: 108061-03-6

Formula: C₁₇H₁₇NO₃

Color and Shape: Off-White Solid

Molecular weight: 283.33

Ref: 4Z-K-0312

Ethyl (1RS)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylate (Ketorolac Ethyl Ester)

Controlled Product

CAS: 108061-03-6

Formula: C₁₇H₁₇NO₃

Color and Shape: Neat

Molecular weight: 283.32

Ref: 86-MM0851.11

Ketorolac Ethyl Ester (Racemic)

Controlled Product

CAS: 108061-03-6

Applications Ethyl-(5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylate, racemic (cas# 108061-03-6) is a useful research chemical.

Formula: C₁₇H₁₇NO₃

Color and Shape: Neat

Molecular weight: 283.32

Ref: TR-E937730

Ethyl-(5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylate, racemic

CAS: 108061-03-6

Ethyl (5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylate, racemic) is a molecule that can be used in the treatment of cardiac diseases. It is a cardiotonic agent that has been shown to shorten the duration of ventricular fibrillation and restore contractility. This drug also decreases the frequency and severity of angina pectoris and enhances coronary artery blood flow. The most effective dose for this drug is 1.5 mg per kg body weight. It is administered orally or intravenously and should not be used with fatty esters because it may cause hypotension. Ethyl (5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylate, racemic) has been shown to have an effect on metal coordination profiles as well as an activated form of the molecule.

Formula: C₁₇H₁₇O₃N

Purity: Min. 98 Area-%

Color and Shape: Off-White Powder

Molecular weight: 283.32 g/mol

Ref: 3D-IE58060

Ketorolac EP Impurity J

CAS: 108061-03-6

Formula: C₁₇H₁₇NO₃

Molecular weight: 283.33

Ref: ST-EA-CP-K4010